News Agency
The Times

Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma

  • Written by PR Newswire
Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma

HEFEI, China, Feb. 25, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. ("Kangpu") today announced that the Company has received IND approval from the CDE (Center for Drug Evaluation) of China National Medical Products Administration (NMPA) for KPG-818 for the treatment of relapsed/refractory multiple myeloma (RRMM).

IND approval record on CDE official websiteIND approval record on CDE...

Read more: Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory...

How to Choose a Local SEO Agency That Can Generate Real Enquiries, Not Just Rankings

A local SEO proposal may promise improved Google Maps visibility, extra keywords, and monthly reports. Those can be useful, but they do not automatically mean the business will receive more calls from suitable customers. Before committing to a contract, owners... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion